ChREBP CRISPR/Cas9 Knockout (KO) Plasmid… and 2 more items

The University of Nebraska Medical Center (UNMC), a state agency under the Board of Regents of the University of Nebraska, awarded a purchase order (PO) valued at $927.00 to Santa Cruz Biotechnology, a vendor located in Dallas, Texas. The contract, issued on September 15, 2026, with a completion date of September 22, 2026, covers the procurement of three biotechnology research plasmids for delivery to UNMC General Supply in Omaha, Nebraska. The products include a ChREBP Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 Knockout plasmid ($397.00), a ChREBP Homology-Directed Repair plasmid ($445.00), and a Control CRISPR/Cas9 plasmid ($85.00), each ordered in a quantity of one unit.

Performance of this contract is scheduled for completion within a seven-day period from issuance through the requested delivery date of September 22, 2026. Shipment terms are Free on Board (F.O.B.) destination with freight prepaid, and payment is established on a Net 30 basis. The contract is governed by the Standard Terms of Purchase at the University of Nebraska and is applicable to UNMC's tax-exempt status (05-8905401). This purchase order represents a routine procurement of specialized molecular biology research materials intended to support genetic research initiatives at the medical center.